Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07367542

Effect of Esketamine on Perioperative Negative Emotions in Patients Undergoing Breast Cancer Surgery

Effect of Continuous Intraoperative Esketamine Infusion on Perioperative Negative Emotions in Patients Undergoing Breast Cancer Surgery: A Randomized Controlled Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
218 (estimated)
Sponsor
Chinese PLA General Hospital · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

A Dual-Center, Randomized, Controlled, Blinded, Prospective Study on the Effects of Esketamine on Perioperative Negative Emotions in Patients Undergoing Breast Cancer Surgery

Conditions

Interventions

TypeNameDescription
DRUGEsketamine 0.3mg/kgA single dose of 0.3 mg/kg esketamine is administered intravenously during anesthesia induction, with the infusion completed over 40 minutes.
DRUGNormal SalineReceiving the same volume of normal saline during induction of anesthesia during the same time

Timeline

Start date
2026-01-17
Primary completion
2027-02-01
Completion
2027-02-01
First posted
2026-01-26
Last updated
2026-01-27

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07367542. Inclusion in this directory is not an endorsement.